Akari Therapeutics Plc (AKTX)
15.68
+0.61
(+4.05%)
USD |
NASDAQ |
Jun 08, 16:00
15.68
0.00 (0.00%)
After-Hours: 16:47
Akari Therapeutics EPS Diluted (Quarterly) : -9.584 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.501 |
| DBV Technologies SA | -0.5577 |
| Cellectis SA | -0.1774 |
| Autolus Therapeutics Plc | -0.2686 |
| Evaxion AS | -0.4366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.43M |
| Total Expenses (Quarterly) | 14.43M |
| Enterprise Value | 15.15M |
| Earnings Yield | -126.3% |